Table 4.
Multivariate analyses of factors associated with 2008 HIV-positive TB mortality rate, N = 114 countries/territories
| Variable | HIV-positive TB mortality ratea |
||||
|---|---|---|---|---|---|
| Unadjusted relative risk |
Adjusted relative risk |
||||
| Estimate (95% CI) | P-value | Estimate (95% CI) | P-value | ||
| Region | Non-African | 1 (−) | <0.0001 | 1 (−) | <0.0001 |
| African | 68.17 (30.26–153.57) | 28.88 (11.71–71.21) | |||
| Government health expenditure at average exchange rate (logarithm of, US$100 per capita) | 0.44 (0.36–0.53) | <0.0001 | 0.73 (0.56–0.95) | 0.0178 | |
| Personal health expenditure as a percentage of total health expenditure (%) | 1.06 (1.03, 1.08) | <0.0001 | 1.02 (1.00–1.05) | 0.1168 | |
| AIDS death rate (logarithm of) | 3.72 (2.07–6.69) | <0.0001 | Not included in final model | ||
| HAART coverage (%) | <15% ≥15% |
1.47 (0.5–4.3) 1 (−) |
0.9548 | Not included in final model | |
a
Note: Natural log-scaled HIV-positive TB mortality rate.
Abbreviations: AIDS, acquired immunodeficiency syndrome; CI, confidence interval; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus; TB, tuberculosis.